IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024
For the year, the company expects to report revenue of $72.0 million to $74.0 million, GAAP diluted earnings per share of $1.37 to $1.47, and non-GAAP diluted earnings per share of $1.52 to $1.62.